|
Thursday 10th March 2016 |
Text too small? |
Trilogy International, the skincare and home fragrance company, raised its guidance for full-year sales and earnings, partly on the contribution from New Zealand cosmetics and fragrance distribution business, CS Company, acquired last August.
Revenue in the 12 months ending March 31 is forecast to exceed $83 million, up from the $75 million-to-$79 million range given at the time of the first-half results and more than double the year-earlier period.
Earnings before interest and tax are expected to exceed $14 million, the top end of its previous guidance and profit before tax is forecast to top $13 million, compared to a previous guidance range of $10 million to $12 million.
Trilogy last year agreed to buy privately held CS Company, New Zealand's largest independent importer and distributor of fragrances, cosmetics and toiletries, for $37 million plus any earn-out payments. The purchase was debt funded. It added to assets including the Trilogy, Ecoya and Goodness brands.
Trilogy shares rose 2.2 percent to $3.30 and have soared 302 percent in the past 12 months.
The company plans to release its full-year results in May and give guidance for the 2017 year.
BusinessDesk.co.nz
No comments yet
Devon Funds Morning Note - 22 April 2026
AGL - Accordant Group Limited announces opening of Rights Offer
April 22nd Morning Report
BPG - Q4 FY26 Update: ARR reaches $26.8m
Devon Funds Morning Note - 21 April 2026
April 21st Morning Report
CHI - Government diesel storage at Marsden Point
April 20th Morning Report
NZK Market Update - Earnings Guidance Upgrade
MEL - Meridian Energy monthly operating report for March 2026